We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.8%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$83B
AUM Growth
+$4.08B
(+5.2%)
Cap. Flow
-$2.07B
Cap. Flow
% of AUM
-2.5%
Top 10 Holdings %
Top 10 Hldgs %
13.18%
Holding
730
New
59
Increased
161
Reduced
398
Closed
45
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Keurig Dr Pepper
KDP
|
+$550M |
| 2 |
Fidelity National Information Services
FIS
|
+$353M |
| 3 |
Global Payments
GPN
|
+$263M |
| 4 |
CVS Health
CVS
|
+$175M |
| 5 |
Devon Energy
DVN
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$433M |
| 2 |
Lowe's Companies
LOW
|
+$277M |
| 3 |
Oracle
ORCL
|
+$226M |
| 4 |
Progressive
PGR
|
+$220M |
| 5 |
Las Vegas Sands
LVS
|
+$167M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.96% |
| 2 | Healthcare | 15.3% |
| 3 | Industrials | 15.12% |
| 4 | Technology | 14.91% |
| 5 | Consumer Discretionary | 11.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Regal Rexnord
RRX
$14B
| $2.3M | ﹤0.01% |
+13,509
| New | +$2.14M |
|
452
JetBlue
JBLU
$2.02B
| $2.27M | ﹤0.01% |
159,504
+46,304
| +41% | +$681K |
|
453
Ventas
VTR
$48.7B
| $2.15M | ﹤0.01% |
42,064
+11,658
| +38% | +$609K |
|
|
BELFB
454
Bel Fuse Inc Class B
BELFB
$3.84B
| $2.13M | ﹤0.01% |
165,104
-1,887
| -1% | -$24.2K |
|
455
Caleres
CAL
$420M
| $2.13M | ﹤0.01% |
93,874
+7,468
| +9% | +$178K |
|
456
Entravision Communication
EVC
$1.02B
| $2.1M | ﹤0.01% |
309,334
+23,941
| +8% | +$181K |
|
457
CACI
CACI
$11B
| $2.08M | ﹤0.01% |
7,734
| – | – |
|
458
1-800-Flowers.com
FLWS
$245M
| $2.05M | ﹤0.01% |
87,625
+38,313
| +78% | +$1.11M |
|
459
Triumph Financial Inc
TFIN
$1.8B
| $2M | ﹤0.01% |
16,813
-70
| -0.4% | -$8.38K |
|
460
IBEX
IBEX
$467M
| $2M | ﹤0.01% |
154,936
-1,704
| -1% | -$27K |
|
|
DBD
461
DELISTED
Diebold Nixdorf Incorporated
DBD
| $1.98M | ﹤0.01% |
218,294
-36,491
| -14% | -$339K |
|
|
PLYM
462
DELISTED
Plymouth Industrial REIT
PLYM
| $1.96M | ﹤0.01% |
61,172
| – | – |
|
463
Argan
AGX
$7.61B
| $1.93M | ﹤0.01% |
49,795
+6,170
| +14% | +$258K |
|
464
AutoNation
AN
$7.1B
| $1.91M | ﹤0.01% |
16,347
-2,757
| -14% | -$332K |
|
465
Brixmor Property Group
BRX
$9.93B
| $1.88M | ﹤0.01% |
74,082
-9,817
| -12% | -$236K |
|
466
Vanguard Value ETF
VTV
$189B
| $1.88M | ﹤0.01% |
+12,776
| New | +$1.82M |
|
467
Warrior Met Coal
HCC
$4.26B
| $1.88M | ﹤0.01% |
73,029
+4,014
| +6% | +$96.5K |
|
|
FFIC
468
DELISTED
Flushing Financial
FFIC
| $1.86M | ﹤0.01% |
76,505
-861
| -1% | -$20.6K |
|
469
Heritage Insurance Holdings
HRTG
$864M
| $1.85M | ﹤0.01% |
315,467
-1,254
| -0.4% | -$8.27K |
|
470
BJ's Restaurants
BJRI
$1.45B
| $1.84M | ﹤0.01% |
53,415
+20,511
| +62% | +$730K |
|
|
BERY
471
DELISTED
Berry Global Group, Inc.
BERY
| $1.81M | ﹤0.01% |
26,699
| – | – |
|
|
BFX
472
DELISTED
BowFlex Inc.
BFX
| $1.78M | ﹤0.01% |
+290,657
| New | +$2.41M |
|
473
Alibaba
BABA
$276B
| $1.78M | ﹤0.01% |
18,979
-4,606
| -20% | -$671K |
|
474
Washington Trust Bancorp
WASH
$736M
| $1.73M | ﹤0.01% |
30,719
-153
| -0.5% | -$8.51K |
|
475
Bausch Health
BHC
$1.67B
| $1.7M | ﹤0.01% |
61,447
| – | – |
|
Similar funds
Boston Partners's Q4 2021 Portfolio in Review
As of Q4 2021, Boston Partners held 730 positions worth $83B, up 5.2% from $78.9B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Boston Partners's Q4 2021 filing shows 59 new, 161 increased, 398 reduced and 45 closed positions. Its largest new stake was Keurig Dr Pepper: 15,605,496 shares worth $575M. The largest sale was Pfizer, an estimated $433M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 22% a quarter earlier, followed by Healthcare and Industrials.
- Boston Partners's largest Q4 2021 buy was Keurig Dr Pepper: 15,605,496 shares worth $575M.
- Boston Partners added most to Fidelity National Information Services in Q4 2021, an estimated $353M increase.
- Boston Partners's biggest Q4 2021 reduction was Pfizer, cutting an estimated $433M.
- Boston Partners fully exited CyrusOne Inc Common Stock in Q4 2021, selling an estimated $137M.
- Boston Partners's ten largest holdings make up 13% of its $83B portfolio in Q4 2021.
- Boston Partners opened 59 new positions and closed 45 in Q4 2021.
- Boston Partners's portfolio value rose 5.2% quarter-over-quarter to $83B.
Based on Boston Partners's 13F filing for Q4 2021, filed 4 Feb 2022.